期刊文献+

经蝶窦入路手术治疗垂体生长激素腺瘤 被引量:3

Transsphenoid surgery of pituitary adenoma of growth hormone
下载PDF
导出
摘要 目的探讨垂体生长激素(GH)腺瘤患者的肿瘤大小、术前GH水平、术中GH的动态变化对手术效果的影响。方法回顾分析47例垂体GH腺瘤,18例术前行口服糖耐量试验(OGTT);均采用经蝶窦入路手术,19例术中检测GH水平,21例术后1个月行OGTT试验。结果术后随访期内临床症状明显缓解的30例,随访期内GH<2.0 ng/ml的有29例,总的缓解率61.7%,其中微腺瘤77.7%、大腺瘤的缓解率是51.7%。结论垂体GH腺瘤患者的早期诊断是提高手术效果的关键,OGTT抑制试验有助于早期诊断;经鼻蝶入路手术是治疗首选,术中GH的动态观察有助于早期判断手术效果,若能及时快速测定GH,将有助于提高缓解率。 Objective To explore the effect of tumor size, preoperative GH and the intraoperative growth hormone (GH) measurement on the operative outcome in pituitary adenoma of GH. Methods The clinical data of 47 patients with aeromegaly wereanalyzed retrospectively . The oral glucose tolerance test was used in pre-operative diagnosis and post-operative evaluation. All the patients were operated through transsphenoid and the intraoperative GH was measured in 19 patients. Results After the operation, the symptoms of acromegaly were significantly relieved in 30patients. According to the criteria of remission, there were 29 (61.7%). However, the remission rate of microadenoma (77.7%) was significantly higher than that in macroadenoma (51.7%). Conclusion The early diagnosis of acromegaly is the crucial of the improvement of surgical outcome. For the doubt cases,OGTT is helpful for the early diagnosis. The transsphenoid approach is the first choice of the treatment of acromegaly. The intraoperative GH measurement is valuable for the early evaluation of surgical outcome. If the intraoperative GH can be rapidly and timely measured, it will be effective to increase the remission rate.
出处 《临床神经外科杂志》 CAS 2011年第5期234-236,共3页 Journal of Clinical Neurosurgery
关键词 肢端肥大症 垂体瘤 经鼻蝶入路手术 acromegaly pituitary adenoma thranssphenoid surgery
  • 相关文献

参考文献7

  • 1Kristof RA, Neuloh G, Redel L, et al. Reliability of the oral glucose tolerance test in the early postoperative assessment of aeromegaly remission[ J]. J Neurosurg,2002,97:1282.
  • 2Ludecke DK, Abe T. Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology[ J ]. 2006,83:230.
  • 3Abe T,Luedecke DK. Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly[ J]. Clin Endocrinol, 999,50:27.
  • 4Tzanela M. Dynamic tests and basal values for detemling active acromegaly [ J]. Neuroendocrinology ,2006,83 : 200.
  • 5Sheppard MC. GH and mortality in acromegaly [ J ]. J Endocrinol Invest ,2005,28:75.
  • 6毛志钢,王海军,何东升,徐伟光,冯雷.影响垂体生长激素腺瘤经蝶手术疗效的因素分析[J].中国微侵袭神经外科杂志,2006,11(4):151-153. 被引量:7
  • 7Colao A, Pivonello R, Cavallo LM,et al. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly [ J ]. Clin Endocrinol (Oxf) ,2006,65:250.

二级参考文献8

  • 1Cottier JP,Destrieux C,Brunereau L,et al.Cavernous sinus invasion by pituitary adenomas:MR Imaging[J].Radiology,2000; 215(2):463-469.
  • 2Melmed S,Casanueva FF,Cavagnini F.et al.Guidelines for acromegaly management[J].J Clin Endocrinol Metab,2002;87(9):4054-4058.
  • 3Holdaway IM,Rajasoorya RC,Gamble GD,et al.Factors influencing mortality in acromegaly[J].J Clin Endocrinol Metab,2004; 89(2):667-674.
  • 4Krieger MD,Couldwell WT,Weiss MH.Assessment of longterm remission of acromegaly following surgery[J].J Neurosurg,2003; 98(4):719-724.
  • 5Zirkzee EJ,Corssmit EP,Biermasz NR,et al.Pituitary magnetic resonance imaging is not required in the postoperative follow-up of acromegalic patients with long-term biochemical cure after transsphenoidal surgery[J].J Clin Endocrinol Metab,2004; 89(9):4320-4324.
  • 6Shimon I,Cohen ZR,Ram Z,et al.Transsphenoidal surgery for acromegaly:endocrinological follow-up of 98 patients[J].Neurosurgery,2001; 48(6):1239-1245.
  • 7De P,Rees DA,Davies N,et al.Transsphenoidal surgery for acromegaly in Wales:results based on stringent criteria of remission[J].J Clin Endocrinol Metab,2003; 88(8):3567-3572.
  • 8Ben-shlomo A,Melmed S.The role of pharmacotherapy in perioperative management of patients with acromegaly[J].J Clin Endocrinol Metab,2003; 88(3):963-968.

共引文献6

同被引文献42

  • 1张宏伟,于春江,闫长祥,孙炜,杨军.垂体微腺瘤的诊断和治疗(附56例报告)[J].中华神经外科杂志,2006,22(6):340-343. 被引量:20
  • 2张亚卓,王忠诚,刘业剑,宗绪毅,赵澎,宋明,裴傲.内镜经鼻蝶入路手术治疗垂体瘤[J].中国微侵袭神经外科杂志,2007,12(2):51-54. 被引量:140
  • 3顾昌伟,陶帮宝,孙青芳.激素在垂体生长激素腺瘤预后判断中的意义[J].中华神经外科疾病研究杂志,2007,6(4):377-378. 被引量:3
  • 4WinnHR,KliotM,BremH,eta1.尤曼斯神经外科学[M].王任直主译.北京:人民卫生出版社,2009.921-921.
  • 5Cuny T, Barlier A, Feelders R, et al. Medical therapies in pituitary adenomas: current rationale for the use and future perspectives[J]. Ann Endocrinol(Paris), 2015, 76(1): 43-58. DOI: 10.1016/j.ando. 2014.10.002.
  • 6Shirvani M, Motiei-Langroudi R. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients [J]. World Neurosurg, 2014, 81(1): 125-130. DOI: 10.1016/j.wneu. 2013.01.021.
  • 7Palmeiro CR, Anand R, Dardi IK, et al. Growth hormone and the cardiovascular system[J]. Cardiol Rev, 2012, 20(4): 197-207. DOI: 10.1018/j.erv.2012.02.020.
  • 8Gondim A, Ferraz T, Mota I, et al. Outcome of surgical intrasellar growth hormone tumor performed by a pituitary specialist surgeon in a developing country[J]. Surg Neurol, 2009, 72(1): 15-19. DOI: 10.1016/j.surneu.2008.02.012.
  • 9Bedogni G, Giannone G, Maghnie M, et al. Serum insulin-like growth factor-I reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in-and out-patients[J]. Growth Horm IGF Res, 2012, 22(3-4): 134-138. DOI: 10.1016/j.ghir.2012.04.005.
  • 10Sarkar S, Rajaratnam S, Chacko G, et al. Endocrinological outcomes following endoscopic and microcopic transsphenoidal surgery in 113 patients with acromegaly[J]. Clin Neurol Neurosurg, 2014, 126: 190-195. DOI: 10.1016/j.clinettro.2014.09.004.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部